Related Experiment Video
Updated: Apr 28, 2026
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
Spatial lipidomics identifies α-synuclein-induced lipid changes in an AAV-induced Parkinsonian mouse model
Yachao He1, Ibrahim Kaya2, Xiaoqun Zhang3
1Department of Neurology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
This study reveals how alpha-synuclein affects brain lipids in Parkinson's disease models. Researchers mapped lipid changes in the substantia nigra and striatum, identifying key alterations in sphingolipids and glycerophospholipids.
Area of Science:
- Neuroscience
- Biochemistry
- Mass Spectrometry Imaging
Background:
- Parkinson's disease (PD) involves alpha-synuclein aggregation and lipid imbalance.
- Lipids are implicated in alpha-synuclein toxicity, but their regulatory role in PD is unclear.
Purpose of the Study:
- To investigate how alpha-synuclein overexpression impacts brain lipid composition spatially.
- To characterize the lipidomic alterations in the nigrostriatal pathway in an experimental Parkinson's model.
Main Methods:
- Utilized dual polarity matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI).
- Analyzed lipid profiles in the substantia nigra and striatum of a unilateral adeno-associated virus (AAV)-alpha-synuclein mouse model.
Main Results:
- Identified region-specific changes in sphingolipids (GM1s, SMs, sulfatides) and glycerophospholipids.
- Observed decreased polyunsaturated fatty acid (PUFA)-containing lipids and increased saturated/mono-unsaturated species.
- Detected elevated oxidized phosphatidylcholines (PCs) and altered ether phosphatidylethanolamines (PEs) in specific brain regions.
Conclusions:
- Provided a comprehensive, spatially resolved lipidomic map of alpha-synuclein pathology in the nigrostriatal pathway.
- Highlighted significant lipid dysregulation in experimental PD, offering potential therapeutic targets.
More Related Videos
08:33Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Published on: February 28, 2016
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
